Fentanyl and the Third Wave: Ohio's Overdose Crisis Explained
Ohio went from prescription pills to heroin to fentanyl in a decade. Understanding the third wave is essential to understanding why MAT access is a life-or-death infrastructure problem.
Ohio's opioid crisis has moved in three distinct waves, each more lethal than the last. The first wave began in the late 1990s when pharmaceutical manufacturers aggressively marketed opioid painkillers as safe and non-addictive, and prescribing rates in Ohio — particularly in the Appalachian southeast and the industrial northeast — soared. By the mid-2000s, Ohio had among the highest opioid prescribing rates in the country, and prescription pill addiction was widespread across demographics that had no prior drug use history.
The Second Wave: From Pills to Heroin
The second wave arrived when prescription supply was tightened through prescriber limits and drug monitoring programs. People dependent on pills shifted to heroin, which was cheaper, widely available, and offered through the same distribution networks that had supplied the pill market. Ohio heroin deaths spiked dramatically between 2010 and 2015. The overdose profile changed: deaths were now concentrated among younger adults, in urban and suburban areas, and the overdoses were faster-onset and harder to reverse than pill-era deaths.
The third wave — fentanyl — arrived around 2016 and has never receded. Illicitly manufactured fentanyl is 50 to 100 times more potent than morphine by weight. A lethal dose is measured in micrograms. It has largely displaced heroin in the Ohio street drug supply, and it now contaminates not just opioid supplies but stimulants, benzodiazepines, and counterfeit pills. A person who used heroin in 2013 and relapses in 2026 is encountering an entirely different drug supply — one where their prior tolerance is irrelevant and the margin for error is effectively zero.
What Fentanyl Changes About MAT
Fentanyl has fundamentally changed the MAT landscape. The case for continuous, uninterrupted buprenorphine or methadone therapy is stronger than it has ever been, because the alternative — any period of abstinence followed by relapse — now carries near-zero tolerance and a dramatically elevated overdose risk. Naloxone availability is more critical because fentanyl overdoses are faster and may require multiple doses to reverse. And the infrastructure problem Live Now Recovery is addressing — real-time visibility into which providers are available right now — is more urgent in a fentanyl era where time from crisis to treatment is measured in hours, not days.